Accuracy of an automated knowledge base for identifying drug adverse reactions

被引:62
|
作者
Voss, E. A. [1 ,2 ,3 ]
Boyce, R. D. [3 ,4 ]
Ryan, P. B. [1 ,3 ,5 ]
van der Lei, J. [2 ,3 ]
Rijnbeek, P. R. [2 ,3 ]
Schuemie, M. J. [1 ,3 ]
机构
[1] Janssen Res & Dev LLC, Epidemiol Analyt, Raritan, NJ USA
[2] Erasmus Univ, Med Ctr, Rotterdam, Netherlands
[3] OHDSI, New York, NY USA
[4] Univ Pittsburgh, Pittsburgh, PA USA
[5] Columbia Univ, New York, NY USA
关键词
Pharmacovigilance; Adverse drug reaction; Machine-learning experiment; Knowledge base; Health outcome; SIGNAL-DETECTION; HOSPITALIZED-PATIENTS; GOLD STANDARD; OUTCOMES; EVENTS; SAFETY; DESIGN;
D O I
10.1016/j.jbi.2016.12.005
中图分类号
TP39 [计算机的应用];
学科分类号
081203 ; 0835 ;
摘要
Introduction: Drug safety researchers seek to know the degree of certainty with which a particular drug is associated with an adverse drug reaction. There are different sources of information used in pharma-covigilance to identify, evaluate, and disseminate medical product safety evidence including spontaneous reports, published peer-reviewed literature, and product labels. Automated data processing and classification using these evidence sources can greatly reduce the manual curation currently required to develop reference sets of positive and negative controls(i.e. drugs that cause adverse drug events and those that do not) to be used in drug safety research. Methods: In this paper we explore a method for automatically aggregating disparate sources of information together into a single repository, developing a predictive model to classify drug-adverse event relationships, and applying those predictions to a real world problem of identifying negative controls for statistical method calibration. Results: Our results showed high predictive accuracy for the models combining all available evidence, with an area under the receiver-operator curve of when tested on three manually generated lists of drugs and conditions that are known to either have or not have an association with an adverse drug event. Conclusions: Results from a pilot implementation of the method suggests that it is feasible to develop a scalable alternative to the time-and-resource-intensive, manual curation exercise previously applied to develop reference sets of positive and negative controls to be used in drug safety research. (C) 2016 Elsevier Inc. All rights reserved.
引用
收藏
页码:72 / 81
页数:10
相关论文
共 50 条
  • [41] The Importance of the Pharmacist in Reporting Adverse Drug Reactions in the Emergency Department
    Ratz, Yael
    Shafir, Irene
    Berkovitch, Sofia
    Sharristh, Moshe
    Jacoby, Moshe
    Kozer, Eran
    Golik, Ahuva
    Berkovitch, Matitiahu
    Bar-Haim, Shmuel
    JOURNAL OF CLINICAL PHARMACOLOGY, 2010, 50 (10) : 1217 - 1221
  • [42] Evaluation of adverse drug reactions in medical intensive care units
    Park, Sojin
    In, Yongwon
    Suh, Gee Young
    Sohn, Kieho
    Kim, Eunyoung
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2013, 69 (01) : 119 - 131
  • [43] Adverse drug reactions in therapeutic hypothermia after cardiac arrest
    Witcher, Robert
    Dzierba, Amy L.
    Kim, Catherine
    Smithburger, Pamela L.
    Kane-Gill, Sandra L.
    THERAPEUTIC ADVANCES IN DRUG SAFETY, 2017, 8 (03) : 101 - 111
  • [44] Identifying adverse drug reactions from patient reviews on social media using natural language processing
    Oyebode, Oladapo
    Orji, Rita
    HEALTH INFORMATICS JOURNAL, 2023, 29 (01)
  • [45] The importance of monitoring adverse drug reactions in pediatric patients: the results of a national surveillance program in Italy
    Carnovale, Carla
    Brusadelli, Tatiana
    Zuccotti, GianVincenzo
    Beretta, Silvia
    Sullo, Maria Giuseppa
    Capuano, Annalisa
    Rossi, Francesco
    Moschini, Martina
    Mugelli, Alessandro
    Vannacci, Alfredo
    Laterza, Marcella
    Clementi, Emilio
    Radice, Sonia
    Acampora, Lanfranco
    Acquaviva, Alessia
    Albano, Raffaele
    Aliberti, Francesco
    Antoniazzi, Stefania
    Azzari, Chiara
    Berni, Roberto
    Bertella, Silvana
    Besana, Roberto
    Biassoni, Veronica
    Blandizzi, Corrado
    Borali, Elena
    Borin, Franca
    Borsadoli, Cecilia
    Boschiero, Anna
    Bussolini, Anna
    Bottone, Roberta
    Carissimi, Angiolina
    Casnaghi, Daniela
    Casullo, Carmela
    Cattaneo, Sarah
    Cherubini, Simonetta
    Chielli, Angela
    Colombo, Roberto Rodolfo
    Cometti, Marina
    Conio, Stefania
    Corradino, Margherita
    Cusmai, Rosa
    De Giacomo, Costantino
    De Rosa, Stefania
    Della Giovanna, Mirosa
    Di Benedetto, Domenica
    Di Maggio, Giuseppe
    Dovera, Eleonora
    Femiano, Pasquale
    Figini, Chiara
    Fiori, Anna Maria
    EXPERT OPINION ON DRUG SAFETY, 2014, 13 : S1 - S8
  • [46] The Knowledge and Reporting of Adverse Drug Reactions in Healthcare Professionals and the Public in China
    Mo, Xiaomei
    Leng, Xiaowei
    Zhang, Jinli
    Du, Ruqiong
    Yang, Xiaofen
    Liu, Ming
    Wang, Jianghai
    Sun, Gang
    Zhang, Chunli
    Wang, Jin
    Yin, Mengting
    Li, Huahui
    Yan, Meixing
    LATIN AMERICAN JOURNAL OF PHARMACY, 2023, 42 (09): : 1948 - 1961
  • [47] Incidence of Adverse Drug Reactions at a University Hospital in Southern Brazil
    Tust, Patricia B.
    Cristina Gonzalez, M.
    LATIN AMERICAN JOURNAL OF PHARMACY, 2011, 30 (10): : 2037 - 2042
  • [48] Mining Adverse Drug Reactions from online healthcare forums using Hidden Markov Model
    Sampathkumar, Hariprasad
    Chen, Xue-wen
    Luo, Bo
    BMC MEDICAL INFORMATICS AND DECISION MAKING, 2014, 14
  • [49] Pharmacists' knowledge and perceptions about pharmacovigilance and barriers towards adverse drug reactions reporting in Yemen
    Zawiah, Mohammed
    Mukred, Ramzi
    Al-Jamei, Sayida
    Kadi, Taha
    Al-Baidani, Abdulrhman
    Abu Farha, Rana
    JOURNAL OF PHARMACEUTICAL HEALTH SERVICES RESEARCH, 2019, 10 (01) : 67 - 72
  • [50] Recognition and reporting of suspected adverse drug reactions by surveyed healthcare professionals in Uganda: key determinants
    Kiguba, Ronald
    Karamagi, Charles
    Waako, Paul
    Ndagije, Helen B.
    Bird, Sheila M.
    BMJ OPEN, 2014, 4 (11):